The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This report finds that 72% of adults now report being at least partially vaccinated for COVID-19, with the surge in cases, hospitalizations, and deaths due to the Delta variant being the main motivator for the recently vaccinated. It also examines the public's views on vaccine mandates, booster doses, and breakthrough infections.
Before the FDA expanded the Pfizer-BioNTech COVID-19 vaccine emergency use authorization for 12 to 15 year olds this week, the latest KFF COVID-19 Vaccine Monitor reported that 30 percent of parents of children ages 12 to 15 said they would get their child vaccinated right away.
The Survey on Race and Health is a joint project between KFF and ESPN’s The Undefeated exploring the public’s views and experiences on health care, racial discrimination, and the coronavirus pandemic. It includes a special focus on the views and experiences of Black Americans, including unconscious bias and structural racism; experiences and trust in the health care system; the social and economic impacts of the pandemic; and views of a potential COVID-19 vaccine.
States have begun to form "health alliances" as a counter to federal public health recommendations and policies under the Trump Administration. This Policy Watch describes the goals of these alliances, and discusses what effects they may have for U.S. public health policy.
This issue brief provides an update on the latest trends in kindergarten children's routine vaccination and exemption rates. Over three-quarters (39) of states had measles, mumps, rubella (MMR)vaccination rates below the “target” rate of 95% for the 2024-2025 school year.
This volume shares updates from the most recent CDC advisory panel meeting, changes to the CDC webpage on autism and vaccines, and polling on trust in news organizations. Additionally, it shares recent developments in AI and social media policy and new KFF poll findings about perceptions of mifepristone’s safety and prevalence.
This volume examines findings about trusted sources of vaccine information from the latest KFF Tracking Poll on Health Information and Trust. It also explores how the misrepresentation of studies and policy developments contribute to health narratives around vaccines, HIV and PrEP. Lastly, it summarizes new research on the use of generative AI to counteract vaccine misinformation.
In his latest column, President and CEO Dr. Drew Altman discusses how midterm political strategy will shape health policy in 2026, focusing on recent moves by President Trump. He writes: “Democrats start out with a significant advantage on health in the midterms, but rather than cut and run to other issues, Trump wants Republicans to try to erode that advantage where they can.”
People with medical conditions that put them at higher risk of developing serious COVID-19 illness are next in line to get vaccinated in many states, though states are making very different choices about how to prioritize those within this large group, finds a KFF analysis of state policies. The U.S. Centers for Disease Control and Prevention (CDC) estimates that there are 81 million adults nationwide with conditions that it identifies as posing an increased risk…
Children between the ages of 6 months and 5 years of age finally became eligible for COVID-19 vaccination in the U.S. on June 18, after the Director of the Centers for Disease Control and Prevention (CDC) recommended their use for this population, following emergency use authorization granted by the Food and Drug Administration. Here, we examine the status of vaccine uptake in this group, one month into their eligibility.
© 2026 KFF